Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-020574

Director sold 27,000 shares at $3.33 ($89,902)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
WILSON TROY EDWARD Director 2024-06-13 Sale 10b5-1 −27,000 $3.33 $89,902 350 D
Open-market sales · 27,000 sh · avg $3.33 · $89,902
Loading xslF345X05/rdgdoc.xml…